Abstract

SARS-CoV-2 has spread very quickly from its first reported case on 19 January 2020 in the United Stated of America, leading WHO to declare pandemic by 11 March 2020. RNA viruses accumulate mutations following replication and passage in human population, which prompted us to determine the rate and the regions (hotspots) of the viral genome with high rates of mutation. We analyzed the rate of mutation accumulation over a period of 11 weeks (submitted between 19th January to 15 April 2020) in USA SARS-CoV-2 genome. Our analysis identified that majority of the viral genes accumulated mutations, although with varying rates and these included NSP2, NSP3, RdRp, helicase, Spike, ORF3a, ORF8, and Nucleocapsid protein. Sixteen mutations accumulated in Spike protein in which four mutations are located in the receptor binding domain. Intriguingly, we identified a fair number of viral proteins (NSP7, NSP9, NSP10, NSP11, Envelop, ORF6, and ORF7b proteins), which did not accumulate any mutation. Limited changes in these proteins may suggest that they have conserved functions, which are essential for virus propagation. This provides a basis for a better understanding of the genetic variation in SARS-CoV-2 circulating in the US, which could help in identifying potential therapeutic targets for controlling COVID-19.

Highlights

  • The outbreak of a severe viral pneumonia in Wuhan, China, 2019, led to the discovery of the new strain of the coronavirus [1]

  • After considering all the exclusion criteria, 196 unique SARS-CoV-2 genome sequences remained to use for mutational analysis

  • The complete sequence of 196 genomes is unique SARS-CoV-2 genome sequences remained to use for mutational analysis

Read more

Summary

Introduction

The outbreak of a severe viral pneumonia in Wuhan, China, 2019, led to the discovery of the new strain of the coronavirus [1]. The International Committee on Taxonomy of Viruses proposed the name SARS-CoV-2, while the name coronavirus disease 19 (COVID-19) was adapted by the World Health Organization (WHO) to avoid confusion with the previous SARS outbreak in. SARS-CoV-2 is a novel member of the Coronaviridae family and belongs to the genus. Coronaviridae consists of two genera, alphacoronavirus and betacoronavirus, infecting humans and causing respiratory problems. Infection is usually mild, while elderly and patients with comorbid factors experience severe and sometimes fatal consequences [8]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.